全文获取类型
收费全文 | 115198篇 |
免费 | 11015篇 |
国内免费 | 7833篇 |
专业分类
耳鼻咽喉 | 1055篇 |
儿科学 | 1372篇 |
妇产科学 | 1510篇 |
基础医学 | 13269篇 |
口腔科学 | 1873篇 |
临床医学 | 14746篇 |
内科学 | 17594篇 |
皮肤病学 | 1172篇 |
神经病学 | 5776篇 |
特种医学 | 4574篇 |
外国民族医学 | 77篇 |
外科学 | 12569篇 |
综合类 | 18928篇 |
现状与发展 | 21篇 |
一般理论 | 21篇 |
预防医学 | 7680篇 |
眼科学 | 2883篇 |
药学 | 12542篇 |
114篇 | |
中国医学 | 6562篇 |
肿瘤学 | 9708篇 |
出版年
2024年 | 346篇 |
2023年 | 1700篇 |
2022年 | 4316篇 |
2021年 | 5531篇 |
2020年 | 4163篇 |
2019年 | 3719篇 |
2018年 | 3974篇 |
2017年 | 3510篇 |
2016年 | 3447篇 |
2015年 | 5082篇 |
2014年 | 6160篇 |
2013年 | 5720篇 |
2012年 | 8334篇 |
2011年 | 8956篇 |
2010年 | 5760篇 |
2009年 | 4556篇 |
2008年 | 6075篇 |
2007年 | 6206篇 |
2006年 | 6008篇 |
2005年 | 5577篇 |
2004年 | 4399篇 |
2003年 | 4426篇 |
2002年 | 3933篇 |
2001年 | 3370篇 |
2000年 | 3062篇 |
1999年 | 2803篇 |
1998年 | 1767篇 |
1997年 | 1679篇 |
1996年 | 1282篇 |
1995年 | 1200篇 |
1994年 | 1044篇 |
1993年 | 605篇 |
1992年 | 896篇 |
1991年 | 741篇 |
1990年 | 643篇 |
1989年 | 606篇 |
1988年 | 465篇 |
1987年 | 406篇 |
1986年 | 331篇 |
1985年 | 256篇 |
1984年 | 161篇 |
1983年 | 120篇 |
1982年 | 85篇 |
1981年 | 98篇 |
1980年 | 58篇 |
1979年 | 83篇 |
1978年 | 39篇 |
1974年 | 36篇 |
1973年 | 33篇 |
1972年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
71.
OBJECTIVES: To assess the effectiveness and safety of additional bedtime H2‐receptor antagonists (H2RAs) in suppressing nocturnal gastric acid breakthrough (NAB) via a systematic review. METHODS: Eligible trials were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 2, 2004), MEDLINE (January 1966–June 2004), EMBASE (January 1980–June 2004) and CINAHL (January 1982–June 2004). Additional hand‐searching was conducted on the proceedings of correlated conferences, eight important Chinese journals and references of all included trials. All randomized controlled trials evaluating H2RAs for the control of NAB were eligible for inclusion. The systematic review was conducted using methods recommended by The Cochrane Collaboration. RESULTS: Only two randomized crossover studies, comprising 32 participants, met the inclusion criteria. Because the design, dosage and duration of the treatments were different between the studies, it was not possible to conduct meta‐analysis. There were no consistent conclusions found between the two included studies in evaluating H2RAs for the control of NAB. CONCLUSIONS: No implications for practice at this stage can be concluded. Appropriately designed large‐scale randomized controlled trials with long‐term follow up are needed to determine the effects of additional bedtime H2RAs in suppressing NAB. 相似文献
72.
Meng Qingyue Li Renzhong Cheng Gang 《中国防痨杂志》2003,25(Z1):22-23
INTRODUCTION: The financial responsibility in health sector was decentralizedfrom central and provincial governments to county and township governments. It was argued that a decentralized system without effective transfer payment mechanism has pushed the poverty area to more disadvantaged positions in economic development in general. 相似文献
73.
Mei-Ju Chen Ching-Yu Cheng Yen-Cheng Chen Ching-Kuang Chou Wen-Ming Hsu 《Journal of ocular pharmacology and therapeutics》2006,22(3):188-193
PURPOSE: The aim of this study was to investigate the effects of bimatoprost 0.03% on ocular hemodynamics in patients with normal tension glaucoma (NTG). METHODS: Twenty-two (22) patients with NTG were consecutively recruited. After basic eye examination and diurnal intraocular pressure (IOP) measurement, color Doppler imaging was used to measure the peak systolic and end diastolic velocities and resistive index of the central retinal, lateral posterior ciliary, and medial posterior ciliary arteries. Patients received bimatoprost 0.03% for 4 weeks, and these measurements were then repeated. The worse eye of each NTG patient was used in the statistical analysis. RESULTS: Bimatoprost 0.03% significantly reduced mean IOP from 15.1 +/- 3.8 mmHg at baseline to 12.0 +/- 2.9 mmHg after treatment in our sample of NTG patients (P < 0.001). No significant changes in blood velocities or resistance indices were observed in the retrobulbar vessels after the 4-week treatment. CONCLUSIONS: Topical bimatoprost 0.03% significantly reduced IOP in our NTG patients without causing significant hemodynamic changes in the retrobulbar vessels. 相似文献
74.
外科学教学中的审美教育 总被引:1,自引:0,他引:1
医学审美教育是医学生全面素质教育不可分割的组成部分,笔者结合长期外科教学实践,阐述了在外科学教学中运用医学美学原理对外科学的美进行开发和挖掘,使医学生在熟练掌握外科学基本理论和基本技能的同时,潜移默化地接受美的教育,美的熏陶,更能激发他们对外科学的热爱和兴趣,达到全面提高医学生整体素质的目的。 相似文献
75.
凯时治疗慢性重型肝炎患者疗效观察 总被引:2,自引:0,他引:2
目的探讨凯时即前列地尔脂微球载体制剂(Lipo-PGE1)治疗慢性重型肝炎的疗效。方法将84例慢性重型肝炎患者随机分成两组,对照组予综合治疗及对症治疗,治疗组在该基础上加用凯时10μg溶于5%葡萄糖注射液250ml中静脉缓慢滴注,1次/d,疗程为4周。结果治疗组对慢性重型肝炎的疗效优于对照组(P〈0.01),肝功能改善优于对照组(P〈0.01)。结论Lipo-PCEI是一种治疗慢性重型肝炎安全、有效的药物。 相似文献
76.
64层CT下肢动脉成像技术研究 总被引:6,自引:0,他引:6
目的探讨64层CT下肢动脉成像强化质量的对比剂注射方式。方法前瞻性地选择60例疑诊下肢动脉病变的病人,利用64层螺旋CT行下肢动脉CT血管成像。采用不同的扫描和重建参数,应用370mgI/100ml浓度的对比剂100ml团注或采用先70ml的对比剂后50ml的0.9%生理盐水用双筒高压注射器分别以4.0ml/s的注射速度团注入肘静脉,应用对比剂追踪触发扫描方式待腹主动脉CT阈值达120HU时延迟7s开始扫描;利用MIP和VR方式重建CTA图像;对比不同参数和不同对比剂应用方式的CT血管成像图像质量。结果最佳的扫描与重建参数为准直64×0.6mm,螺距1.5,层厚1.0,重建间隔50%;最佳的对比剂应用方式为(浓度为370mgI/100ml)对比剂70ml、生理盐水50ml以4.0ml/s注射速度按先后顺序团注。结论选择合适的准直、螺距以保证适当的扫描速度,选择合适的对比剂浓度、用量和注射速度以保证血管内足够的对比剂峰值浓度及峰值持续时间,此二者是64层CT下肢动脉成像成功的关键。 相似文献
77.
Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation 总被引:3,自引:0,他引:3
Yong Wang Zheng Tang Shuming Ji Zhen Zhang Jinsong Chen Zhen Cheng Dongrui Cheng Zhihong Liu Leishi Li 《Transplant international》2006,19(12):1006-1013
The aim of the study was to analyse the clinical manifestation and management of pulmonary Lophomonas blattarum infection in four allograft transplantation recipients retrospectively. Four patients with pulmonary L. blattarum infection were diagnosed by using Fiberoptic bronchoscopy (FOB) and bronchoalveolar lavage (BAL) examination. Their clinical manifestation and management are summarized. Four cases of pulmonary L. blattarum were found during the period from the second month to the third month after transplantation. Concurring infection by other pathogens was found in three of them. Common initial symptoms included fever (>38 degrees C) without cough and breathlessness. Lower lobe shadowing could be found on chest X-ray. Body temperature decreased to the normal range in three patients and to 37.5 degrees C in the other one, after intravenous injection of metronidazole and tapering immunosuppressant. Radiological examination confirmed improved health condition of the patients afterwards. Two patients received repeated FOB and only dead L. blattarum was found. Pulmonary L. blattarum infection in allograft transplant recipients carry relatively obscure initial symptoms. Possible L. blattarum infection needs to be screened in post-transplantation pulmonary infection patients with similar symptoms, especially in those who respond poorly to anti-infection treatment. Microscopic examination of BAL fluid can help to identify pulmonary L. blattarum infection and metronidazole is an ideal treatment choice. 相似文献
78.
79.
(加味)柴芍承气汤对重症急性胰腺炎及其并发症的作用 总被引:2,自引:1,他引:1
目的探讨(加味)柴芍承气汤对重症急性胰腺炎(SAP)及其并发症的防治作用。方法65例SAP患者分为中药组35例,对照组30例。2组的内科治疗相同,中药组一经确诊即予柴芍承气汤加味银杏叶治疗,每剂煎成100~150m l,自鼻胃管内注入或口服,每日2~3次,直至患者腹痛缓解、腹胀基本消失、肠鸣恢复。分别观察2组患者治疗72 h后的PaO2、SaO2肾功能、脑病、局部并发症情况、腹痛缓解时间、肠鸣恢复时间、病死率,以及血清中血小板活化因子(PAF)、肿瘤坏死因子(TNF-α)、白介素-1(IL-1)水平变化。结果治疗72 h后中药组与对照组低氧血症的发生率分别为45.71%、73.73%,P<0.05;肾损害、脑病、局部并发症发生率以及病死率均低于对照组,但无统计学差异;腹痛缓解时间、肠鸣恢复时间均优于对照组(P<0.05);中药组血清中PAF、TNF-α、IL-1水平显著降低(P<0.01),而对照组则无明显变化。结论该汤剂对SAP及其并发症有较好的防治作用。抑制细胞因子或炎症介质可能是该汤剂治疗SAP的重要机制。 相似文献
80.
目的探讨利用人UroplakinⅡ(hUPⅡ)启动子进行靶向性基因治疗膀胱癌的可能性。方法将hUPⅡ启动子和肿瘤坏死因子-α(TNF-α)克隆到腺病毒载体Ad5中,构建重组体pAd-hUPⅡ-TNF。转染细胞293后产生复制缺陷型的重组腺病毒,感染膀胱癌细胞系BIU-87,检测TNF-α对BIU-87细胞体外生物学行为及体内成瘤性的影响。结果成功构建pAd-hUPⅡ-TNF重组腺病毒载体,转染细胞293获得复制缺陷型重组腺病毒。BIU-87细胞经重组腺病毒感染后可产生高浓度的TNF-α,并降低BIU-87的生长速度。感染腺病毒的BIU-87培养液可抑制L929细胞的生长。裸鼠原位膀胱肿瘤动物模型实验结果表明膀胱灌注重组腺病毒48h后,裸鼠尿液含高浓度的TNF-α,4周后腺病毒组膀胱重量和体积明显低于对照组(P<0.01)。结论hUPⅡ启动子TNF-α为治疗基因的重组腺病毒可特异性使膀胱癌细胞系BIU-87产生高浓度的TNF-α,并降低BIU-87和L929细胞的生长速度。重组腺病毒可使裸鼠尿内含高浓度的TNF-α,并可抑制裸鼠原位膀胱肿瘤动物模型膀胱癌细胞的成瘤性。 相似文献